1. Introduction

Biological inheritance governance refers to the legal, ethical, scientific and institutional framework governing the transmission of biological characteristics, genetic information and hereditary material from one generation to another. It addresses how governments, courts, healthcare institutions, research organizations and private companies should regulate genetic inheritance while protecting human dignity, individual autonomy, privacy, equality and the rights of future generations.

Biological inheritance includes naturally occurring genetic transmission from parents to children as well as legal questions arising from genetic testing, hereditary diseases, reproductive technologies, genetic modification, donor conception, surrogacy and the storage or commercial use of genetic information.

The subject is particularly important because advances in biotechnology have made it possible to identify inherited conditions, predict certain disease risks and potentially alter genetic material. These developments create difficult questions: Who controls genetic information? Can employers or insurers discriminate based on hereditary risks? Should parents be permitted to make genetic decisions affecting future children? What safeguards should apply to heritable genome editing?

There is no single universally recognized legal doctrine called the “Biological Inheritance Governance Doctrine.” Rather, it is a useful interdisciplinary concept drawing on constitutional law, medical law, bioethics, privacy law, family law, equality law and biotechnology regulation.

2. Meaning and scope of biological inheritance governance

The framework can be divided into six principal areas.

A. Genetic information and privacy

Genetic information can reveal sensitive facts about an individual and biological relatives. Governance must regulate its collection, storage, disclosure, sharing and secondary use.

For example, a genetic test may identify a person's susceptibility to an inherited condition while also revealing that a sibling or child may share the same risk. The law must balance individual confidentiality against narrowly defined circumstances in which disclosure could prevent serious harm.

B. Equality and non-discrimination

A person's genetic characteristics should not automatically determine their access to employment, education, insurance, healthcare or public benefits. Governance must distinguish legitimate, evidence-based medical decisions from unjustified discrimination based on genetic predictions.

C. Reproductive autonomy and family rights

Genetic counselling, prenatal testing, preimplantation genetic testing, donor conception and assisted reproductive technologies raise questions about informed consent, parental autonomy, the welfare of future children and the legal status of genetic parenthood.

D. Heritable genome editing

Changes to reproductive cells or embryos may affect descendants who cannot consent to the intervention. Governance must address scientific safety, uncertainty, oversight, intergenerational consequences and the risk of eugenic practices.

E. Ownership and commercial exploitation

Genetic samples and genetic data may be used in medical research, pharmaceutical development and commercial testing. Relevant issues include consent, benefit-sharing, intellectual property, data security and the rights of Indigenous communities over genetic resources and associated traditional knowledge.

F. Intergenerational justice

Decisions about genetic technologies may produce consequences extending beyond the individual who authorizes them. Governance therefore considers the interests of future generations, including their health, autonomy, privacy and freedom from avoidable biological harm.

3. Constitutional and statutory framework in India

In India, biological inheritance governance is not governed by one comprehensive statute. Its legal foundation is spread across constitutional protections, data-protection law, reproductive-health legislation, family law and biomedical research regulation.

A. Constitution of India

The most relevant constitutional provisions are:

Article 14 — Equality before law: Genetic characteristics should not become an arbitrary basis for unequal treatment by the State.

Article 21 — Life, liberty and dignity: Protects privacy, bodily autonomy and personal liberty, which are relevant to genetic testing and reproductive decisions.

Article 19(1)(a) — Freedom of speech and expression: May be relevant to access to and dissemination of scientific information, subject to lawful restrictions.

Article 15 — Prohibition of discrimination: May become relevant where genetic or hereditary classifications intersect with constitutionally prohibited grounds of discrimination.

The constitutional analysis depends on the nature of the decision, the institution involved and the rights affected. Article 14 is particularly relevant to State action, while Article 21 also informs the constitutional obligations surrounding bodily autonomy and informational privacy.

B. Digital Personal Data Protection Act, 2023

Genetic information held in digital form may fall within the framework of India's Digital Personal Data Protection Act, 2023, where the statutory conditions apply. The Act regulates the processing of digital personal data and provides obligations concerning lawful processing, consent, security and individual rights, subject to its provisions and exceptions.

A significant distinction is that India's framework does not simply replicate the special-category genetic-data regime found in some other jurisdictions. Consequently, the precise legal treatment of a genetic database depends on the Act's applicable provisions, rules and exemptions.

C. Assisted reproductive technology and surrogacy legislation

The Assisted Reproductive Technology (Regulation) Act, 2021, and the Surrogacy (Regulation) Act, 2021, establish regulatory frameworks for relevant reproductive services and practices.

These laws are important where genetic inheritance intersects with donor gametes, embryos, surrogacy, clinical standards, consent and the responsibilities of registered institutions.

D. Medical and research regulation

Other potentially relevant instruments include the Medical Termination of Pregnancy Act, 1971, the Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, and applicable biomedical research guidelines.

In particular, the PCPNDT Act seeks to prevent sex selection and the misuse of prenatal diagnostic techniques. It illustrates an important principle of biological governance: reproductive technologies must not become instruments of discriminatory selection.

4. Leading case laws

The following decisions do not all concern inherited DNA directly. They establish legal principles relevant to privacy, genetic testing, reproduction, equality and the evidentiary use of biological information.

Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Court: Supreme Court of India.

Legal issue: Whether the right to privacy is constitutionally protected.

Decision and principle: A nine-judge bench recognized privacy as a fundamental right protected by Article 21 and other freedoms in Part III of the Constitution. It emphasized that privacy is connected with dignity, autonomy and informational self-determination. Restrictions must satisfy constitutional requirements, including legality, a legitimate State aim and proportionality.

Indian Kanoon

+1

Application to biological inheritance governance:

Suppose a private laboratory collects DNA samples and shares genetic risk profiles with third parties without an appropriate legal basis. The privacy principles in Puttaswamy provide a constitutional framework for evaluating State involvement and inform the broader legal discussion of data protection.

The judgment also supports scrutiny of compulsory genetic testing by public authorities. Such testing should not be treated as automatically lawful merely because it may produce useful information.

Significance: This is a foundational Indian authority for protecting genetic privacy, although it does not establish a standalone, absolute right to genetic-data ownership.

Case 2: Sharda v. Dharmpal (2003) 4 SCC 493

Court: Supreme Court of India.

Legal issue: Whether a court can direct a medical examination in matrimonial proceedings.

Decision and principle: The Supreme Court held that a matrimonial court has power in appropriate circumstances to order a medical examination. It also recognized that unjustified refusal may permit an adverse inference, depending on the circumstances. The power must be exercised judicially, not routinely or arbitrarily.

Application to biological inheritance governance:

A genetic examination in a parentage dispute or a medical examination relevant to an alleged hereditary condition may involve competing interests: the need for reliable evidence and the individual's privacy and bodily autonomy.

Sharda is relevant by analogy to the judicial balancing exercise. It should not be read as authorizing compulsory DNA testing in every family dispute.

Case 3: Bhabani Prasad Jena v. Convenor Secretary, Orissa State Commission for Women (2010) 8 SCC 633

Court: Supreme Court of India.

Legal issue: Whether DNA testing should be ordered in a dispute concerning paternity.

Decision and principle: The Court held that DNA testing should not be ordered mechanically. Courts must consider the necessity of the test, the evidence already available, the interests of the parties and the consequences of intruding into privacy and family relationships.

Application to biological inheritance governance:

This decision is central to the governance of genetic evidence in family law. It demonstrates that scientific accuracy is not the only relevant consideration: courts must also examine whether testing is legally necessary and proportionate.

For example, a parentage dispute should not automatically result in a DNA test merely because one party requests it. The court must assess the circumstances and applicable law.

Significance: The judgment helps prevent the unrestricted use of genetic testing as a routine litigation tool.

Case 4: Banarsi Dass v. Teeku Dutta (2005) 4 SCC 449

Court: Supreme Court of India.

Legal issue: The evidentiary use of DNA testing in paternity disputes.

Decision and principle: The Supreme Court cautioned against treating DNA testing as an automatic solution in every paternity dispute. The court must consider the applicable law, the existing evidence and the implications of ordering a test.

Application: Biological inheritance governance must account for the interaction between scientific evidence and legal presumptions concerning parentage. A genetic result may be highly probative, but the manner in which it is obtained, admitted and interpreted remains legally significant.

Case 5: Suchita Srivastava v. Chandigarh Administration (2009) 9 SCC 1

Court: Supreme Court of India.

Legal issue: Reproductive autonomy and the termination of pregnancy.

Decision and principle: The Supreme Court recognized reproductive choice as an aspect of personal liberty under Article 21. The judgment emphasized the importance of a woman's autonomy in decisions concerning reproduction, subject to the applicable legal framework.

Application to biological inheritance governance:

Genetic screening and prenatal diagnosis can influence reproductive decisions. The principles in Suchita Srivastava are relevant when evaluating whether individuals are being pressured or coerced into reproductive choices based on genetic findings.

The case does not create an unrestricted right to select or modify inherited characteristics. Rather, it provides an important autonomy-based framework for reproductive decision-making.

Case 6: Goutam Kundu v. State of West Bengal (1993) 3 SCC 418

Legal issue: Whether courts can routinely compel blood testing to establish paternity.

Principle: The Supreme Court cautioned that blood tests should not be ordered as a matter of course. Courts must examine the strength of the initial case, the applicable legal presumptions and the consequences of testing. These principles were subsequently discussed in Bhabani Prasad Jena.

Sci API

+1

Governance significance: Biological evidence must be subject to procedural safeguards. A person's genetic information should not be obtained through an unrestricted evidentiary inquiry.

Case 7: Bragdon v. Abbott, 524 U.S. 624 (1998)

Court: Supreme Court of the United States.

Legal issue: Whether an asymptomatic HIV infection could qualify as a disability under the Americans with Disabilities Act.

Principle: The Court held that HIV infection could constitute a disability even before the most serious symptoms appeared. Its analysis considered the effect of the infection on major life activities, including reproduction.

LII / Legal Information Institute

+1

Application: The decision illustrates why biological conditions and medically established risks must be assessed carefully when applying equality protections. However, HIV infection is not itself a hereditary genetic condition, and the judgment is not a direct ruling on genetic discrimination.

Case 8: Chaturbhuj Pradhan v. Amar Pradhan (2026 INSC 600)

Court: Supreme Court of India.

Legal issue: When can DNA testing be ordered in a civil paternity dispute?

Principle: In its judgment of 29 May 2026, the Supreme Court addressed circumstances in which DNA testing may be justified where paternity is directly in issue and other evidence is insufficient. The decision emphasizes balancing privacy interests against the legitimate interest in determining biological parentage and inheritance rights.

LawFinder Live

+1

Application: This decision is particularly relevant to contemporary biological inheritance governance because genetic testing can affect identity, family relationships and succession claims. It reinforces the need for judicial assessment rather than automatic testing.

5. International approaches to biological inheritance governance

United States: Genetic Information Nondiscrimination Act, 2008

The Genetic Information Nondiscrimination Act (GINA) restricts the use of genetic information in employment decisions and health insurance. Employment protections include restrictions on acquiring and disclosing genetic information, subject to exceptions. GINA does not prohibit every possible use of genetic information in every insurance context.

U.S. Equal Employment Opportunity Commission

+1

European Union: GDPR

The General Data Protection Regulation treats genetic data as a special category of personal data under Article 9. Processing is generally prohibited unless an applicable exception or condition permits it. This provides a more explicit special-category framework for genetic data than India's general digital personal-data legislation.

UNESCO: Human Genome and Human Rights

UNESCO's 1997 Universal Declaration on the Human Genome and Human Rights articulates principles of human dignity, non-discrimination and responsible scientific research. It is an international declaration rather than a directly enforceable global statute.

6. Major legal challenges

A. Genetic discrimination

A person may have a genetic predisposition to a condition without ever developing it. Treating that prediction as proof of incapacity can produce unjustified exclusion.

Governance response: Require evidence-based decision-making, confidentiality safeguards and effective remedies against unlawful discrimination.

B. Consent and family privacy

Genetic information is inherently relational: a person's test result can reveal information about biological relatives who have not consented to testing.

Governance response: Use clear consent procedures, explain foreseeable implications for relatives, restrict secondary use and establish carefully defined exceptions for serious risks.

C. Reproductive technology and embryo selection

Preimplantation genetic testing can help identify embryos carrying known hereditary diseases. It also raises concerns about the selection of embryos for non-medical characteristics and discriminatory attitudes toward disability.

Section 25 of India's Assisted Reproductive Technology (Regulation) Act, 2021, provides that preimplantation genetic testing is to be used to screen embryos for known, pre-existing heritable or genetic diseases.

IndiaCode

+1

Governance response: Enforce statutory limits, require appropriate clinical oversight and distinguish disease prevention from non-medical selection.

D. Heritable genome editing

Editing reproductive cells or embryos can potentially introduce changes that persist across generations. Unintended effects may not become apparent until much later.

Governance response: Apply rigorous scientific review, independent ethics oversight, transparent authorization procedures and safeguards against premature clinical use. A governance framework must also consider future generations, who cannot consent to inherited interventions.

E. Genetic data commercialization

Companies may collect DNA samples or genetic profiles for ancestry services, research and drug development.

Governance response: Clarify permitted purposes, retention periods, data-sharing arrangements, commercial reuse and deletion rights. Contractual consent should not be treated as unlimited permission for every future use.

7. Principles of an effective biological inheritance governance framework

A coherent governance framework should incorporate the following principles:

Human dignity: Genetic differences must not determine a person's social worth.

Informed consent: Individuals should understand the purpose, implications and limits of genetic testing.

Privacy and confidentiality: Genetic information should be protected against unauthorized access and disclosure.

Equality: Hereditary risks should not become an arbitrary basis for exclusion.

Scientific validity: Genetic tests must be appropriately validated and their results interpreted in context.

Proportionality: Compulsory testing or disclosure should be justified by a legitimate purpose and appropriate safeguards.

Intergenerational responsibility: Decisions affecting descendants require careful assessment of long-term consequences.

Accountability: Laboratories, healthcare providers, researchers and regulators should be subject to enforceable standards and appropriate remedies.

8. Conclusion

Biological inheritance governance concerns the lawful and ethical management of genetic information, hereditary risks, reproductive choices and biological evidence across generations. Its central objective is to ensure that scientific advances serve human welfare without undermining privacy, dignity, equality or autonomy.

In India, Puttaswamy provides the foundational constitutional privacy framework, while Sharda, Goutam Kundu, Banarsi Dass and Bhabani Prasad Jena help explain the limits on compulsory biological testing. Suchita Srivastava informs reproductive autonomy, and the Assisted Reproductive Technology (Regulation) Act, 2021, establishes specific statutory controls relevant to genetic screening in reproductive treatment.

The central legal principle is that biological information may be scientifically powerful, but its collection and use must remain subject to law, individual rights, evidentiary safeguards and accountable institutions. Biological inheritance should inform responsible healthcare and lawful decision-making, not become a mechanism for discrimination, coercion or the arbitrary control of future generations.

Academic note: The cited judgments address distinct legal questions; they should not be presented as if the courts had established a single, comprehensive doctrine of biological inheritance governance. For litigation or formal academic submission, verify the current statutory text, subsequent judicial treatment and the precise facts of each cited decision.